ArticleNAR cancer2025

IGF1R-targeted delivery of a bridged nucleic acid oligonucleotide-peptide conjugate for microRNA-21 inhibition in triple-negative breast cancer.

Yuanyuan Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.